Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Treatment improved symptoms in a woman with HAIR-AN syndrome.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Too much androgen can cause hair loss; finasteride may help.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.